Alnylam Pharmaceuticals
ALNY
ALNY
355 hedge funds and large institutions have $15.8B invested in Alnylam Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 124 increasing their positions, 129 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 373 → 355 (-18)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
35% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 49
Holders
355
Holding in Top 10
7
Calls
$121M
Puts
$131M
Top Buyers
| 1 | +$123M | |
| 2 | +$35.4M | |
| 3 | +$21.8M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$20.1M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$10.8M |
Top Sellers
| 1 | -$88.2M | |
| 2 | -$72.4M | |
| 3 | -$54M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$53.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$48.7M |